KR820000202B1 - Method for preparing auranofin - Google Patents
Method for preparing auranofin Download PDFInfo
- Publication number
- KR820000202B1 KR820000202B1 KR7801082A KR780001082A KR820000202B1 KR 820000202 B1 KR820000202 B1 KR 820000202B1 KR 7801082 A KR7801082 A KR 7801082A KR 780001082 A KR780001082 A KR 780001082A KR 820000202 B1 KR820000202 B1 KR 820000202B1
- Authority
- KR
- South Korea
- Prior art keywords
- acetyl
- water
- auranofin
- chloroform
- tetra
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Abstract
Description
본 발명은 2,3,4,6, 테트라-0-아세틸글루코피라노실 반응에스테르를 1가 알칼리금속 황화물의 존재하에 트리에틸포스핀 골드 크로라이드와 반응시켜 오라노핀(auranofin)을 제조하는 신규화학적 방법에 관한 것이다.The present invention provides a novel chemical for the production of auranofin by reacting a 2,3,4,6, tetra-0-acetylglucopyranosyl reaction ester with triethylphosphine gold chromide in the presence of a monovalent alkali metal sulfide. It is about a method.
오라노핀은 인간에게 항 관절염제처럼 활성치료제이다. [J.Med.chem 15 1095(1972) :미합중국 특허 번호 제3,635,945호]Oranopine is an active therapeutic agent in humans, like anti-arthritis. [J.Med.chem 15 1095 (1972): United States Patent No. 3,635,945]
합성공정은 다음 공식으로 표현된다.The synthesis process is represented by the formula:
상기 반응식에서 Y는 반응하는 할로겐 예를 들어 브롬이나 염소같은 반응하는 에스테르 잔류물 잔여그룹이나 토실옥시(톨루엔설포닐옥시) 부로실옥시(P-브로모페닐설포닐옥시)트리플르오로메탄 설포닐옥시나 메실옥시(메탄설포닐옥시)같은 아릴이나 저급알킬 설포닐옥시이며 Ac는 아세틸이고 M은 칼륨이나 나트륨같은 1가 알칼리금속이며 X는 Y에서 정의된 잔여 그룹이나 바람직하게는 염소, 브롬이나 요오드이다.In the above scheme, Y is a reactive halogen residue such as bromine or chlorine or tosyloxy (toluenesulfonyloxy) brosyloxy (P-bromophenylsulfonyloxy) trifluoromethane sulfonyl Aryl or lower alkyl sulfonyloxy, such as oxy or mesyloxy (methanesulfonyloxy), Ac is acetyl, M is a monovalent alkali metal such as potassium or sodium, X is the remaining group defined in Y, preferably chlorine, bromine It is iodine.
편이상 Y는 염소나 브롬이며 X도 역시 염소, 브롬이나 요오드인 것이 바람직하다. 설탕 시작물질(I)의 1-위치에서의 배열은 α나 β어느쪽이나 나타낸다. 당분야의 전문가들은 α-할로의 치환을 오라노핀에서 나타난 원하던 β-배열을 나타낼 것이라는 것을 인식할 것이다.Preferably, at least Y is chlorine or bromine and X is also chlorine, bromine or iodine. The arrangement in the 1-position of the sugar starting material (I) represents either α or β. Those skilled in the art will recognize that the substitution of α-halo will represent the desired β-configuration seen in oranopine.
다른편에 토실옥시와 같은 에스테르 시작물질을 함유하는 황은 전문가들이 오라노핀 생성반응에서 배열에 불변을 기대할 수 있으므로 β-배열일 것이다(SN1).Sulfur containing ester starting materials, such as tosyloxy, on the other hand would be β-arrays, as experts can expect the array to be invariant in oranopine production (SN1).
"잔여그룹(leaving group)"이란 당 분야에서 본 경우에는 트리에틸포스핀골드티오 그룹인 친핵그룹으로 치환된 약 염기 이온성 그룹으로 정의된다. 모리슨과 보이드의 제3판 유기화학(1973)참조하라. 상기 정의한 바대로 잔여그룹은 친핵치환반응도중 생성된 반응하는 할로나 설포닐옥시 부분이다.A "leaving group" is defined in the art as a weakly basic ionic group substituted with a nucleophilic group which is a triethylphosphinegoldthio group. See Morrison and Boyd, Third Edition Organic Chemistry (1973). As defined above, the remaining group is the reactive halo or sulfonyloxy moiety generated during the nucleophilic substitution.
상기반응은 거의 동몰량의 반응 2, 3, 4, 6-테트라-0-아세틸-α-D-글루코피라노실 에스테르(I), 반응 트리에틸포스핀골드(I) 할라이드(Ⅱ) 및 나트륨이나 칼륨설파이드(Ⅲ)을 반응제를 접촉시킬 수 있는 용매계에서 반응시켜 편리하게 실시할 수 있다. 예를 들어 유기/물의 불활성 이상계를 가장 편리하게 사상할 수 있다. 가장 일반적으로 사용되는 유기용매는 사염화탄소, 크로로포름, 2염화메틸렌, 4염화에틸렌이나 0-디크로로벤젠같은 할로겐화된 탄화수소 용매이다. 벤젠, 톨루엔 크실렌 같은 벤젠노이드 용매 시클로 헥산과 같은 탄화수소용매 등의 기타 물과 혼합할 수 없는 유기용매도 사용가능하다. 이것은 할로겐화된 탄화수소보다 이점이 적다.The reaction was carried out in approximately equimolar amounts of reactions 2, 3, 4, 6-tetra-0-acetyl-α-D-glucopyranosyl ester (I), reaction triethylphosphine gold (I) halide (II) and sodium, The potassium sulfide (III) can be conveniently carried out by reacting in a solvent system capable of contacting the reactant. For example, the inert ideal system of organic / water can be most conveniently mapped. The most commonly used organic solvents are halogenated hydrocarbon solvents such as carbon tetrachloride, chloroform, methylene dichloride, ethylene tetrachloride or 0-dichlorobenzene. Organic solvents that cannot be mixed with other water, such as benzene, solvent benzene, such as benzene, toluene xylene, hydrocarbon solvents, such as cyclohexane, can also be used. This is less advantageous than halogenated hydrocarbons.
한편 크라운에테르같은 상전이 촉매를 부가하여 사용할 수 있다.Meanwhile, a phase transfer catalyst such as crown ether can be added and used.
반응조건은 당 분야의 전문가들에 의하여 변화될 수 있으나 바람직하게는 실온에서시간 동안 혹은 반응이 완성될 때까지 교반하여 반응을 진행시킨다. 반응도중 환류온도까지 가열할 수 있으나 잇점은 없으며 고비등 용매를 사용할 경우 반응온도는 약 75℃로 제한된다.The reaction conditions may be changed by those skilled in the art, but preferably at room temperature The reaction proceeds by stirring for a time or until the reaction is completed. It can be heated to the reflux temperature during the reaction, but there is no advantage, the reaction temperature is limited to about 75 ℃ when using high boiling solvent.
반응하는 시작물질은 당 분야에 R.L 위슬러의 다수인의 공저 카보하이드레이트 화학 2권 434페이지 (1963)에 기록된 2, 3, 4, 6-테트라-0-아세틸-α-D-클루코피라노실할라이드, 브롬이 대표적인 것으로 공지되어 있다. 다른 것도 유사하게 제조한다. 대표적 토실, 부로실, 트리플루오로메탄설포닐 및 메실에스테르는 예컨대 2, 3, 4, 6-테트라에세틸-β-글르코스로부터 상기 책의 244-245페이지에서 개발한 일반 반응법으로 제조하였다.The starting materials to react are 2, 3, 4, 6-tetra-0-acetyl-α-D-glucopyranosyl, recorded in the field of RL Whistler's co-carbohydrate chemistry, Vol. 2, page 434 (1963). Halides, bromine are known to be representative. Others are made similarly. Representative tosyl, brosyl, trifluoromethanesulfonyl and mesyl esters were prepared, for example, from 2, 3, 4, 6-tetracetyl-β-glucos by the general reaction method developed on pages 244-245 of the book. .
3차 포스틴골드 할라이드는 B.M. 서론의 다수인 공저 J.Med.chem 15, 1097 (1972)에 기술되어 있다.The third postingold halide is B.M. A number of introductory publications are described in co-author J. Med.chem 15, 1097 (1972).
반응생성물은 표준 방법으로 단리하였다. 예컨대 유기층은 분리 세척 증발하여 원하던 존 모라 노핀을 얻었는데 이는 크로마토그라피나 분별 결정화 반응에 의하여 정화시킬 수 있다.The reaction product was isolated by standard methods. For example, the organic layer was separated, washed and evaporated to obtain the desired John Moranovine, which can be purified by chromatography or fractional crystallization.
알칼리 금속 설파이드는 우선 3차 -포스핀골드 할라이드와 반응하여 역으로 설탕에스테르와 반응하는 3차-포스핀콜드티올의 나트륨염을 생성한다고 본다. 현단계에선 상기 반응공정에 대한 메카니즘을 얻지 못하고 있다.Alkali metal sulfides are believed to first produce sodium salts of tert-phosphine cold thiols which react with tert-phosphine gold halides and, conversely, sugar esters. At this stage, no mechanism for the reaction process is obtained.
하기 실시예는 본 발명의 실시를 보여주기 위한 것이며 본 발명의 범주를 제한하는 것이 아니다. 모든 온도는 섭씨이다.The following examples are intended to illustrate the practice of the invention and do not limit the scope of the invention. All temperatures are in degrees Celsius.
[실시예 1]Example 1
20ml의 물에 용해된 1.2g(5밀리몰)의 1수화 황화나트륨의 혼합물에 20ml의 크로로포름과 20ml의 물에 용해된 2.0g(5밀리몰)의 2, 3, 4, 6-테트라-0-아세틸-α-D-글루코피라노실브로마이드와 1.7g(5밀리몰)의 테트라 에틸포스핀 골드(I) 클로라이드를 가하였다. 실온에서 1시간동안 교반한 후에 층을 분리하였다. 크로로포름층을 세척하고 마그네슘설페이트로 건조하고 여과한 후 여과물을 감압하에 증발시켜 유상조 오라노핀(auraanoin)을 생성하였다. 이 물질을 크로로포름을 사용한 알루미늄(woelm)관을 통과시켜 고체 오라노핀을 얻은후 에탄올-물에서 재결정하여 백색고체를 얻었다.20 g of chloroform and 2.0 g (5 mmol) of 2, 3, 4, 6-tetra-0 dissolved in 20 ml of chloroform and 20 ml of water in a mixture of 1.2 g (5 mmol) of monohydrate sodium sulfide dissolved in 20 ml of water. -Acetyl-α-D-glucopyranosylbromide and 1.7 g (5 mmol) of tetraethylphosphine gold (I) chloride were added. After stirring for 1 hour at room temperature the layers were separated. The chloroform layer was washed, dried over magnesium sulfate, filtered, and the filtrate was evaporated under reduced pressure to yield an oily crude auraanoin. This material was passed through a woelm tube using chromoform to obtain a solid oranopine, and then recrystallized from ethanol-water to obtain a white solid.
융점 99-102℃(1%메탄올)=-52.4℃Melting Point 99-102 ° C (1% methanol) = -52.4 degrees Celsius
황화칼륨 및 2, 3, 4, 6-테트라-0-아세틸-α-D-글루코피라노실 코로라이드를 치환하여 유사생성물을 수득하였다. 염화메틸렌을 크로로포름으로 치환시킬 수도 있다.Similar products were obtained by substituting potassium sulfide and 2, 3, 4, 6-tetra-0-acetyl-α-D-glucopyranosyl corrolide. Methylene chloride can also be substituted with chloroform.
[실시예 2]Example 2
3.4g(10밀리몰)의 트리에틸포스핀골드(I) 크로라이드와 80ml의 염화메틸렌-30ml의 물에 용해된 10밀리몰의 1-β-토실옥시 2, 3, 4, 6-테트라-0-아세틸글루코스 및 10밀리몰의 황화칼륨의 혼합물을 0℃에서 1시간동안 교반하고 실온에서 5시간동안 교반하였다. 유기층을 분리하고 세척하고 여과하고 여과물을 증발하여 실시예 1에서처럼 정화된 조 오라노핀을 수득하였다.10 mmol of 1-β-tosyloxy 2, 3, 4, 6-tetra-0- dissolved in 3.4 g (10 mmol) of triethylphosphine gold (I) chromide and 80 ml of methylene chloride-30 ml of water. A mixture of acetylglucose and 10 mmol potassium sulfide was stirred at 0 ° C. for 1 hour and at room temperature for 5 hours. The organic layer was separated, washed, filtered and the filtrate was evaporated to give crude oranopine which was purified as in Example 1.
[실시예 3]Example 3
1.0g(1.5밀리몰)의 비스[(트리에틸포스핀)]오러스] 설파이드[Asut. J. chem 19, 547(1966) 크로로포름-물에서 황화나트륨과 2몰당량의 트리에틸포스핀크로라이드를 반응시켜 제조함]와 0.6g(1.5밀리몰)의 2,3,4,6-테트라-0-아세틸-α-D-글루코피라노실 브로마이드의 크로로포름 용액을 실온에서 48시간동안 교반하였다. 용매를 감압하에 제거하였다. 잔류물을 실리카겔에서 벤젠-에테르(0→50%)로 정화하였다.1.0 g (1.5 mmol) bis [(triethylphosphine)] orus] sulfide [Asut. J. chem 19, 547 (1966) chromoform, prepared by reacting sodium sulfide with 2 molar equivalents of triethylphosphine chloride in water; and 0.6 g (1.5 mmol) of 2,3,4,6- The chloroform solution of tetra-0-acetyl-α-D-glucopyranosyl bromide was stirred for 48 hours at room temperature. The solvent was removed under reduced pressure. The residue was purified by benzene-ether (0 → 50%) on silica gel.
생성물을 정화하여 오라노핀을 수득하였다.The product was purified to give oranopine.
융점 109-111℃(1%메탄올)=-53.3℃Melting point 109-111 degrees Celsius (1% methanol) = -53.3 ° C
한편, 크로로포름에 용해된 브롬이 사용된 크로로포름 -물 혼합물에 첨가하여 황화물을 단리시키지 않고 비스 설파이드를 생성할 수 있다.On the other hand, bromine dissolved in chromoform can be added to the used chromoform-water mixture to produce bis sulfide without isolating sulfides.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR7801082A KR820000202B1 (en) | 1978-04-14 | 1978-04-14 | Method for preparing auranofin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR7801082A KR820000202B1 (en) | 1978-04-14 | 1978-04-14 | Method for preparing auranofin |
Publications (1)
Publication Number | Publication Date |
---|---|
KR820000202B1 true KR820000202B1 (en) | 1982-03-04 |
Family
ID=19207404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR7801082A KR820000202B1 (en) | 1978-04-14 | 1978-04-14 | Method for preparing auranofin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR820000202B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230173317A (en) | 2022-06-17 | 2023-12-27 | 한국바이오켐제약 주식회사 | Method for preparing auranofin and auranofin prepared thereby |
-
1978
- 1978-04-14 KR KR7801082A patent/KR820000202B1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230173317A (en) | 2022-06-17 | 2023-12-27 | 한국바이오켐제약 주식회사 | Method for preparing auranofin and auranofin prepared thereby |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU496730A3 (en) | The method of obtaining derivatives of isoindoline or their salts | |
US4131732A (en) | Method for preparing auranofin | |
KR820000202B1 (en) | Method for preparing auranofin | |
US3468900A (en) | Process for preparing isoxazole compounds | |
US4125711A (en) | Process for preparing auranofin | |
JPH0725708B2 (en) | Synthesis of perfluoroalkyl bromide | |
NO145308B (en) | PROCEDURE FOR THE PREPARATION OF AURANOFINE | |
EP0125887B1 (en) | Synthesis of thiazoles | |
US3308132A (en) | 6, 8-dithiooctanoyl amides and intermediates | |
WO1979000172A1 (en) | Process for manufacturing substantially pure dialkyl phosporochloridothionates | |
JPH0130832B2 (en) | ||
GB2137193A (en) | Chlorosulphonic Acid Esters | |
US4311849A (en) | Process for making 3-(N-arylamino)-gamma-butyrothiolactones | |
JP2680906B2 (en) | Synthesis of N-chlorothio-sulfonamide | |
SU136371A1 (en) | Method for producing alkylphosphonic acid derivatives | |
SU891686A1 (en) | Method of preparing 8-mercaptoadenosine | |
GB1586996A (en) | Method for preparing auranofin | |
SU1109407A1 (en) | Process for preparing trimethyl tetrathiophosphate | |
US4452992A (en) | Process for the production of ethoxycarbonylmethyl 5-(2,6-dichloro-4-trifluoro-methylphenoxy)-2-nitro-α-phenoxy-propionate | |
JPS6210236B2 (en) | ||
KR100337037B1 (en) | Process for preparing intermediates of pyridone carboxylic acid derivatives | |
SU432144A1 (en) | METHOD OF OBTAINING N-PYRAZOLYLBUTENINES | |
SU1129210A1 (en) | Process for preparing 3-chloro-1-methylpropene-1-yl dichlorophosphate | |
SU1105495A1 (en) | Method of obtaining dichloranhydride-2-alkoxyvinylphosphonic acids | |
JPH0415233B2 (en) |